Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1095 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Roche, Caliper Life in co-marketing agreement

Roche’s NimbleGen SeqCap EZ Library solution will be used for Caliper’s Sciclone NGS Workstation. The transaction aims to simplify targeted resequencing workflows by developing automated methods for sequencing

Pinnaclife releases prenatal care package

Darlene McCord is senior researcher at McCord Research and Pinnaclife. The Pinnaclife Prenatal Care Plan provides expecting mothers with the brand of vitamin supplements which is based upon

Upsher-Smith rolls out Trianex 0.05%

Trianex 0.05% is formulated with a proprietary hydrous emulsified base that assists maintain moisture to soften and smooth the skin. Trianex is available in 17g and 85g tubes

4SC HCC drug receives FDA orphan drug status

Resminostat, which is an oral pan-histone-deacetylase (HDAC) inhibitor, is currently being evaluated in Phase II SHELTER study as a second-line treatment for advanced hepatocellular carcinoma as well as

Sinapis Pharma concludes Phase I stroke drug trial

The single-center, open-label, randomized, two-period, two-treatment, two-sequence, single dose, crossover study assesed the safety and pharmacokinetics of oral and IV administration of methamphetamine HCl in six healthy volunteers.

USPTO issues NoA for PROLOR CTP platform

CTP platform helps in extending the duration of activity of virtually all therapeutic proteins. The clinical and preclinical studies demonstrate that CTP technology is safe and effective in

FDA allows USANA to manufacture OTC drugs

USANA manufactures over 90% of its products in-house, including all of its tableted nutritional supplements. As an FDA-registered facility, USANA now has the ability to manufacture OTC drugs